ALPRAZOLAM
Generic: ALPRAZOLAM
Actavis PharmaManufacturer
ORALRoute
ALPRAZOLAMActive Substance
1993-10-31Original Approval
ALPRAZOLAM is FDA application ANDA074342, sponsored by ACTAVIS ELIZABETH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-28
alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 079Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
Class II2013-10-09
Alprazolam Orally Disintegrating Tablets, USP 2 mg, 100 count bottles, Rx Only, MFG. BY ACTAVIS ELIZABETH LLC., ElizabetFailed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below speci
Class II2014-12-17
Alprazolam tablets, USP, CIV, 0.25 mg, Rx Only, a) 500 count bottle, b) 1000 count bottle, Distributed by: Greenstone LLSubpotent Drug
Class II2014-07-25
Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets, Sandoz Inc., Princeton, NJ --- NDC 0781-1061-10Presence of Foreign Substance; tablets may contain stainless steel metal particulates
Class II2014-02-10
Alprazolam 1 mg Tablets, USP, 500 count Bottle, Rx Only , C IV, Manufactured by: Actavis Elizabeth LLC 200 Elmora AvenueFailed Tablet/Capsule Specifications: Complaints were received for significant tablet erosion for Al
Top Reported Reactions
1
DRUG ABUSE
8,877 reports
2
TOXICITY TO VARIOUS AGENTS
7,974 reports
3
COMPLETED SUICIDE
7,291 reports
4
DRUG INEFFECTIVE
7,205 reports
5
NAUSEA
5,873 reports
6
FATIGUE
5,592 reports
7
DEATH
5,137 reports
8
HEADACHE
4,662 reports
9
PAIN
4,539 reports
10
ANXIETY
4,398 reports